Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient

Creative Commons License

Erkayman M. H., Bilen H.

TRANSPLANT INFECTIOUS DISEASE, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1111/tid.13572
  • Dergi Adı: TRANSPLANT INFECTIOUS DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: COVID-19, favipiravir, human papillomavirus, solid organ transplant, warts
  • Atatürk Üniversitesi Adresli: Evet

Özet

Human papillomavirus (HPV), a DNA virus, infects basal keratinocytes and causes common warts and as well as malignancies of skin and mucous membranes. Although many treatment options are available, persistent HPV infections are common among transplant recipients. Herein, we present a patient with a 15-year history of treatment-resistant warts that regressed during COVID-19 (Coronavirus disease 2019) treatment.